Buffalo: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.
Buffalo: Confirmation letter
Buffalo: Securities report - 42nd period (April 1, 2023 - March 31, 2024)
Buffalo: Extraordinary Report
Buffalo: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
Kirin HD, Takeda Pharmaceutical, Sumitomo, SoftBank (9th)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------5/9 (Thu) <1375>Snow Country Maitake <1720>Tokyu Construction<1738>Nittoh <1764>Kudo Construction<1788>Santo Kogyo <1799>Daiichi Kenset<1869>Meikouken <1870>Yahagi Kenset<1929
Buffalo: Notice regarding the recording of extraordinary losses (individual accounts) and differences from the previous fiscal year's actual values for individual results
Buffalo: Notice regarding the recording of impairment losses at consolidated subsidiaries, revisions to consolidated earnings forecasts, and revisions to year-end dividend forecasts (dividend increases)
No Data
No Data